Search results
Cannabis and/or cannabinoid access and use by adults with cancer has outpaced the science supporting their clinical use. This guideline provides strategies for open, nonjudgmental communication between clinicians and adults with cancer about the use of cannabis and/or cannabinoids.
- Cannabis Use in Patients With Cancer: A Clinical Review
Cannabis use and interest continues to increase among...
- Cannabis Use in Patients With Cancer: A Clinical Review
13 mar 2024 · Adults with cancer using cannabis or cannabinoids should understand that the clinical evidence to support their use as cancer-directed therapy in humans is lacking.
26 mar 2024 · Clinicians should advise patients against using cannabis and/or cannabinoids in place of cancer-directed treatment (a strong recommendation based on very low-quality evidence). 1
24 cze 2022 · Cannabis use and interest continues to increase among patients with cancer and caregivers. High-quality research remains scant in many areas, causing hesitancy or discomfort among most clinical providers.
25 cze 2024 · ASCO convened a guideline Expert Panel that culled through 366 publications to identify 13 systematic literature reviews, 4 randomized controlled trials, and 1 cohort study on the efficacy and safety of cannabis and cannabinoids in adults with cancer.
11 mar 2022 · Drugs that target the endocannabinoid system are of interest as pharmacological options to combat cancer and to improve the life quality of cancer patients.
24 cze 2023 · Among adults undergoing cancer treatment, 26% reported cannabis use in the past 30 days. Those who used cannabis were more likely to be male and disabled and to have lower income and Medicaid insurance than those who did not use cannabis.
